Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.00427-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Aa Haeruman Azam und 9 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutic Drugs and Vaccine Development Research Center, National Institute of Infectious Diseases, Toyama-ku, Shinjuku, Tokyo, Japan. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Escherichia coli O157, Escherichia coli Infections, Fosfomycin. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED).
Abstract (Originalsprache)
Escherichia coli O157:H7 is a globally important foodborne pathogen with implications for food safety. Antibiotic treatment for O157 may potentially contribute to the exacerbation of hemolytic uremic syndrome, and the increasing prevalence of antibiotic-resistant strains necessitates the development of new treatment strategies. In this study, the bactericidal effects and resistance development of antibiotic and bacteriophage monotherapy were compared with those of combination therapy against O157. Experiments involving continuous exposure of O157 to phages and antibiotics, along with genetic deletion studies, revealed that the deletion of glpT and uhpT significantly increased resistance to fosfomycin. Furthermore, we found that OmpC functions as a receptor for the PP01 phage, which infects O157, and FhuA functions as a receptor for the newly isolated SP15 phage, targeting O157. In the glpT and uhpT deletion mutants, additional deletion in ompC , the receptor for the PP01 phage, increased resistance to fosfomycin. These findings suggest that specific phages may contribute to antibiotic resistance by selecting the emergence of gene mutations responsible for both phage and antibiotic resistance. While combination therapy with phages and antibiotics holds promise for the treatment of bacterial infections, careful consideration of phage selection is necessary. IMPORTANCE The combination treatment of fosfomycin and bacteriophages against Escherichia coli O157 demonstrated superior bactericidal efficacy compared to monotherapy, effectively suppressing the emergence of resistance. However, mutations selected by phage PP01 led to enhanced resistance not only to the phage but also to fosfomycin. These findings underscore the importance of exercising caution in selecting phages for combination therapy, as resistance selected by specific phages may increase the risk of developing antibiotic resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Therapeutic Drugs and Vaccine Development Research Center, National Institute of Infectious Diseases, Toyama-ku, Shinjuku, Tokyo, Japan.
- School of Life Science and Technology, Tokyo Institute of Technology, Nagatsutacho, Yokohama, Japan.
- Division of Bacteriology, Department of Infection and Immunity, Jichi Medical University, Shimotsukeshi, Tochigi, Japan.
ORCID-Profile: Aa Haeruman Azam, Yasunori Tanji, Kotaro Kiga
Förderung
- Japan Agency for Medical Research and Development (AMED)
Zitieren
APA
Azam, A. H., Sato, K., Miyanaga, K., Nakamura, T., Ojima, S., Kondo, K., Tamura, A., Yamashita, W., Tanji, Y., & Kiga, K. (2024). Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00427-23
Vancouver
Azam AH, Sato K, Miyanaga K, Nakamura T, Ojima S, Kondo K, et al. Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00427-23
BibTeX
@article{Azam2024,
author = {Azam, Aa Haeruman and Sato, Koji and Miyanaga, Kazuhiko and Nakamura, Tomohiro and Ojima, Shinjiro and Kondo, Kohei and Tamura, Azumi and Yamashita, Wakana and Tanji, Yasunori and Kiga, Kotaro},
title = {Selective bacteriophages reduce the emergence of resistant bacteria in bacteriophage-antibiotic combination therapy},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.00427-23}
}
EUVIMED